Carlos Roman, Sedano Heddie O
Faculty of Medicine, University Francisco Marroquin, Guatemale City, Guatemala.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Feb;93(2):161-6. doi: 10.1067/moe.2002.119971.
Four cases of central giant cell granuloma were treated with intralesional infiltration of a solution of Kenacort-A (10 mg/mL, triamcinolone aqueous suspension SQUIBB) and either (1) Lidocaine 2% with epinephrine 1:200,000 Marcaine or (2) Bupivacaine, 50% mixture by volume. These cases were originally diagnosed by radiographic and histologic studies in 3 Guatemalan males--ages 31, 34, and 6 years old--and a 21/2-year-old Guatemalan girl. The average dosage of the aforementioned solution was 6 mL (equivalent to 30 mg of triamcinolone) for the adults and 5 mL (equivalent to 25 mg of triamcinolone) for the pediatric patients. Before treatment, an endocrinologist evaluated all of the patients to rule out hyperparathyroidism. Also before treatment, an incisional biopsy of the lesion was obtained from each patient for microscopic examination. Follow-up radiographs for all the cases showed progressive improvement and eventual resolution of the lesions.
4例中央巨细胞肉芽肿患者接受了康宁克通-A溶液(10mg/mL,曲安奈德水性混悬液,施贵宝公司生产)病灶内注射治疗,注射溶液中分别加入了(1)2%利多卡因和1:200,000肾上腺素的麻卡因或(2)体积比为50%的布比卡因。这些病例最初经影像学和组织学检查确诊,患者包括3名危地马拉男性,年龄分别为31岁、34岁和6岁,以及一名2岁半的危地马拉女孩。上述溶液的平均剂量,成人患者为6mL(相当于30mg曲安奈德),儿科患者为5mL(相当于25mg曲安奈德)。治疗前,一名内分泌学家对所有患者进行了评估,以排除甲状旁腺功能亢进症。同样在治疗前,从每位患者的病灶处取组织进行切开活检,以供显微镜检查。所有病例的随访X光片显示病灶逐渐改善并最终消退。